1987•PubMedRequires access

[Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old].

Vázquez Fernández E, F López Rois, Vázquez Carrete Ja, Gómez Tato B, Alvarez Ares M

Open publisher page 0 citations

Abstract

Vaccine coverage, morbidity prevalence, and immunity to measles, rubella, and mumps, were estimated in 1985-1986 among a sample of 2 to 5 years old Galician children, studied through questionnaires and immunoenzymatic determinations of antibodies. According to the mothers, measles vaccine and measles-mumps-rubella vaccine were administered to 22.1% and 45.7%, respectively, of their children, whereas measles were reported in 17.9, mumps in 14.3%, and rubella in 2.9%. The seroconversion to rubella (50.7%) resulted significantly lower (p less than 0.001) than that to measles (75%) or mumps (68.6%). The three types of antibodies were found altogether in 32.1% of the subjects, and 5% of them showed none of these antibodies. The analysis of the serologic data stresses the need for reaching rapidly higher vaccination rates.

About this research paper

What this paper is about

Vaccine coverage, morbidity prevalence, and immunity to measles, rubella, and mumps, were estimated in 1985-1986 among a sample of 2 to 5 years old Galician children, studied through questionnaires and immunoenzymatic determinations of antibodies. According to the mothers, measles vaccine and measles-mumps-rubella vaccine were administered to 22.1% and 45.7%, respectively, of their children, whereas measles were reported in 17.9, mumps in 14.3%, and rubella in 2.9%. The seroconversion to rubella (50.7%) resulted significantly lower (p less than 0.001) than that to measles (75%) or mumps (68.6%). The three types of antibodies were found altogether in 32.1% of the subjects, and 5% of them showed none of these antibodies. The analysis of the serologic data stresses the need for reaching rapidly higher vaccination rates.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Vaccine coverage, morbidity prevalence, and immunity to measles, rubella, and mumps, were estimated in 1985-1986 among a sample of 2 to 5 years old Galician children, studied through questionnaires and immunoenzymatic determinations of antibodies. According to the mothers, measles vaccine and measles-mumps-rubella vaccine were administered to 22.1% and 45.7%, respectively, of their children, whereas measles were reported in 17.9, mumps in 14.3%, and rubella in 2.9%. The seroconversion to rubella (50.7%) resulted significantly lower (p less than 0.001) than that to measles (75%) or mumps (68.6%). The three types of antibodies were found altogether in 32.1% of the subjects, and 5% of them showed none of these antibodies. The analysis of the serologic data stresses the need for reaching rapidly higher vaccination rates.

Key concepts: Medicine, Measles, Rubella, Seroconversion, Vaccination, MMR vaccine, Measles-Mumps-Rubella Vaccine, Population

Related papers

Back to paper searchBrowse research topicsOriginal source
[Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old]. — Research Paper | ScholarLens